These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30793827)

  • 1. The views of people with joint hypermobility syndrome on its impact, management and the use of patient-reported outcome measures. A thematic analysis of open-ended questionnaire responses.
    Palmer S; Bridgeman K; Di Pierro I; Jones R; Phillips C; Wilson M
    Musculoskeletal Care; 2019 Jun; 17(2):183-193. PubMed ID: 30793827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the Bristol Impact of Hypermobility questionnaire to discriminate between people with and without Joint Hypermobility Syndrome: a known-group validity study.
    Palmer S; Macconnell S; Willmore A
    Musculoskeletal Care; 2020 Mar; 18(1):29-36. PubMed ID: 31944577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care.
    Terry RH; Palmer ST; Rimes KA; Clark CJ; Simmonds JV; Horwood JP
    Fam Pract; 2015 Jun; 32(3):354-8. PubMed ID: 25911504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and initial validation of the Bristol Impact of Hypermobility questionnaire.
    Palmer S; Cramp F; Lewis R; Gould G; Clark EM
    Physiotherapy; 2017 Jun; 103(2):186-192. PubMed ID: 27567344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiotherapy management of joint hypermobility syndrome--a focus group study of patient and health professional perspectives.
    Palmer S; Terry R; Rimes KA; Clark C; Simmonds J; Horwood J
    Physiotherapy; 2016 Mar; 102(1):93-102. PubMed ID: 26116487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, assessment, and management of adults with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type among Flemish physiotherapists.
    Rombaut L; Deane J; Simmonds J; De Wandele I; De Paepe A; Malfait F; Calders P
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):76-83. PubMed ID: 25821093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative evaluation of the appropriateness, validity, acceptability, feasibility and interpretability of the Bristol Impact of Hypermobility (BIoH) questionnaire.
    Manns S; Cramp F; Lewis R; Clark EM; Palmer S
    Musculoskelet Sci Pract; 2018 Dec; 38():69-76. PubMed ID: 30312837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States Physical Therapists' Knowledge About Joint Hypermobility Syndrome Compared with Fibromyalgia and Rheumatoid Arthritis.
    Russek LN; LaShomb EA; Ware AM; Wesner SM; Westcott V
    Physiother Res Int; 2016 Mar; 21(1):22-35. PubMed ID: 25504938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-retest reliability and smallest detectable change of the Bristol Impact of Hypermobility (BIoH) questionnaire.
    Palmer S; Manns S; Cramp F; Lewis R; Clark EM
    Musculoskelet Sci Pract; 2017 Dec; 32():64-69. PubMed ID: 28881227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised.
    Sinibaldi L; Ursini G; Castori M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):97-106. PubMed ID: 25821094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait biomechanics in joint hypermobility syndrome: a spatiotemporal, kinematic and kinetic analysis.
    Alsiri N; Cramp M; Barnett S; Palmer S
    Musculoskeletal Care; 2020 Sep; 18(3):301-314. PubMed ID: 32086882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, injury rate and, symptom frequency in generalized joint laxity and joint hypermobility syndrome in a "healthy" college population.
    Russek LN; Errico DM
    Clin Rheumatol; 2016 Apr; 35(4):1029-39. PubMed ID: 25930211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an out-patient pain management programme for people with joint hypermobility syndrome.
    Rahman A; Daniel C; Grahame R
    Clin Rheumatol; 2014 Nov; 33(11):1665-9. PubMed ID: 24557080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Management and Assessment of Adults with Joint Hypermobility Syndrome: A UK-Wide Survey of Physiotherapy Practice.
    Palmer S; Cramp F; Lewis R; Muhammad S; Clark E
    Musculoskeletal Care; 2015 Jun; 13(2):101-11. PubMed ID: 25784539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.
    Krahe AM; Adams RD; Nicholson LL
    Disabil Rehabil; 2018 Aug; 40(17):1989-1996. PubMed ID: 28482708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life prediction in children with joint hypermobility syndrome.
    Pacey V; Tofts L; Adams RD; Munns CF; Nicholson LL
    J Paediatr Child Health; 2015 Jul; 51(7):689-95. PubMed ID: 25622801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint hypermobility is a marker for anxiety in children.
    Bulbena-Cabre A; Duñó L; Almeda S; Batlle S; Camprodon-Rosanas E; Martín-Lopez LM; Bulbena A
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):68-76. PubMed ID: 30926372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Colombi M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):1-5. PubMed ID: 25821089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Dordoni C; Morlino S; Sperduti I; Ritelli M; Valiante M; Chiarelli N; Zanca A; Celletti C; Venturini M; Camerota F; Calzavara-Pinton P; Grammatico P; Colombi M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):43-53. PubMed ID: 25655071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Morlino S; Pascolini G; Blundo C; Grammatico P
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):54-75. PubMed ID: 25821092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.